General information about company

Name of The CompanyMEDI-CAPS LIMITED
BSE Scrip Code523144
NSE SymbolNOTLISTED
MSE SymbolNOTLISTED
Date of Start of Financial Year01-04-2024
Date of End of Financial Year31-03-2025
Reporting PeriodFirst half yearly
Date of Start of Reporting Period01-04-2024
Date of End of Reporting Period30-09-2024
Level of rounding to be used in disclosing related party transactionsLakhs
Whether the company has any related party?Yes
Whether the company has entered into any Related Party transaction during the selected half year for which it wants to submit disclosure?Yes



(I) We declare that the acceptance of fixed deposits by the bans/Non-Banking Finance Company are at the terms uniformly applicable/offered to all shareholders/publicNA
(II) We declare that the scheduled commercial bank, as per RBI circular RBI/DBR/2015-16/19 dated March 03, 2016, has allowed additional interest of one per cent per annum, over and above the rate of interest mentioned in the schedule of interest rates on savings or a term deposits of bank’s staff and their exclusive associations as well as on deposits of Chairman, Chairman & Managing Director, Executive Director or such other Executives appointed for a fixed tenure.NA
(III) Whether the company is a ‘high value debt listed entity’ according to regulation 15 (1A)?No
(a) If answer to above question is Yes, whether complying with proviso to regulation 23 (9), i.e., submitting RPT disclosures on the day of results publication?
(b) If answer to above question is No, please explain the reason for not complying.
Whether the updated Related Party Transactions (RPT) Policy (in compliance with Reg. 23 of SEBI LODR) has been uploaded on the website of the Company?Yes
Latest Date on which RPT policy is updated25-05-2022
Indicate Company website link for updated RPT policy of the Companyhttps://www.medicaps.com/upload/RPT-Policy-W.E.F-25.07.2018-Final-Updated.pdf






Related party transactions

Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken.
Sr No.Details of the party (listed entity /subsidiary) entering into the transactionDetails of the counterpartyType of related party transactionDetails of other related party transactionValue of the related party transaction as approved by the audit committeeRemarks on approval by audit committeeValue of transaction during the reporting periodIn case monies are due to either party as a result of the transactionIn case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investmentsDetails of the loans, inter-corporate deposits, advances or investmentsNotes
NamePANNamePANRelationship of the counterparty with the listed entity or its subsidiaryOpening balanceClosing balanceNature of indebtedness (loan/ issuance of debt/ any other etc.)Details of other indebtednessCostTenureNature (loan/ advance/ intercorporate deposit/ investment )Interest Rate (%)TenureSecured/ unsecuredPurpose for which the funds will be utilised by the ultimate recipient of funds (endusage)
1MEDI-CAPS LIMITEDAABCM1905GHEMANT SETHICJQPS4931MCFO Remuneration25APPROVE BY AUDIT COMMITTEE7.581.420.55Textual Information(1)
2MEDI-CAPS LIMITEDAABCM1905GABHISHEK JAINBYWPK5427JCOMPANY SECRETARY & COMPLIANCE OFFICERRemuneration10APPROVE BY AUDIT COMMITTEE3.420.570.57Textual Information(2)
3MEDI-CAPS LIMITEDAABCM1905GALOK K. GARGAAHPG5352JPROMOTER AND KMP (MD) OF THE COMPANY Remuneration84APPROVE BY AUDIT COMMITTEE4277Textual Information(3)
4MEDI-CAPS LIMITEDAABCM1905GAKSHIT GARGBSJPG4756KGeneral Manager & Relative of KMP of the companyRemuneration30APPROVE BY AUDIT COMMITTEE152.52.5Textual Information(4)
5MEDI-CAPS LIMITEDAABCM1905GSALONI GARGAFUPA8271LSenior Manager & Relative of KMP of the companyRemuneration24APPROVE BY AUDIT COMMITTEE1202Textual Information(5)
6MEDI-CAPS LIMITEDAABCM1905GMEDICAPS CHARITABLE TRUSTAABTM1123FENTITY OVER WHICH DIRECTORS SIGNIFICANT INFLUENCE Any other transactionRENT RECEIVED6APPROVE BY AUDIT COMMITTEE1.50.50Textual Information(6)
7MEDI-CAPS LIMITEDAABCM1905GYOGITA SETHIFTYPS2791QRELATIVE OF CFOAny other transactionCONSULTANCY5APPROVE BY AUDIT COMMITTEE100Textual Information(7)
8MEDGEL PRIVATE LIMITEDAAECM9146JMRS. MANISHA GARGADOPG7990APerson belonging to promoter group and KMP (WTD) of wholly owned subsidiary CompanyRemuneration36APPROVE BY AUDIT COMMITTEE1833Textual Information(8)
9MEDGEL PRIVATE LIMITEDAAECM9146JMR. PRAVEEN NALWAYAACZPN7157NKMP (WTD) of wholly owned subsidiary CompanyRemuneration72APPROVE BY AUDIT COMMITTEE27.754.624.62Textual Information(9)
10MEDGEL PRIVATE LIMITEDAAECM9146JMR. LOKESH PARMAR BMSPP3821PChief Financial Officer of wholly owned subsidiary CompanyRemuneration10APPROVE BY AUDIT COMMITTEE4.260.710.71Textual Information(10)
11MEDGEL PRIVATE LIMITEDAAECM9146JVAIBHAV SINGHAIBEQPS8022DCompany Secretary of wholly owned subsidiary CompanyRemuneration5APPROVE BY AUDIT COMMITTEE2.020.330.33Textual Information(11)
12MEDGEL PRIVATE LIMITEDAAECM9146JMRS. SANDHYA NALWAYAAOPN9487CManager & Relative of KMP of wholly owned subsidiaryRemuneration25APPROVE BY AUDIT COMMITTEE10.711.781.78Textual Information(12)
13MEDGEL PRIVATE LIMITEDAAECM9146JMR. PALASH GARGCQIPG1108HVice President & Relative of KMP of wholly owned subsidiary CompanyRemuneration7APPROVE BY AUDIT COMMITTEE30.50.5Textual Information(13)
14MEDI-CAPS LIMITEDAABCM1905GMEDGEL PRIVATE LIMITEDAAECM9146JWholly owned SubsidiaryInvestmentNA04282.354282.35Textual Information(14)
Total value of transaction during the reporting period148.24